Statement Of Cash Flows [Abstract]

Egetis Therapeutics - Filing #690710

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
1,938,000,000 SEK
1,045,000,000 SEK
Adjustments to reconcile profit (loss) [abstract]
Other adjustments for non-cash items
94,000,000 SEK
27,000,000 SEK
Adjustments to reconcile profit (loss)
109,000,000 SEK
283,000,000 SEK
Interest paid, classified as operating activities
1,000,000 SEK
0 SEK
Interest received, classified as operating activities
9,000,000 SEK
1,000,000 SEK
Income taxes paid (refund), classified as operating activities
- SEK
- SEK
Cash flows from (used in) operating activities
1,735,000,000 SEK
1,301,000,000 SEK
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
17,000,000 SEK
50,000,000 SEK
Purchase of property, plant and equipment, classified as investing activities
- SEK
2,000,000 SEK
Cash flows from (used in) investing activities
17,000,000 SEK
60,000,000 SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
1,774,000,000 SEK
SEK
Repayments of borrowings, classified as financing activities
75,000,000 SEK
75,000,000 SEK
Payments of lease liabilities, classified as financing activities
16,000,000 SEK
14,000,000 SEK
Cash flows from (used in) financing activities
1,557,000,000 SEK
89,000,000 SEK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
195,000,000 SEK
1,450,000,000 SEK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
32,000,000 SEK
11,000,000 SEK
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
195,000,000 SEK
1,450,000,000 SEK
Cash and cash equivalents
1,277,000,000 SEK
1,440,000,000 SEK
2,879,000,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.